Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
US Department of Justice
Cantor Fitzgerald
US Army

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,508,905

« Back to Dashboard

Summary for Patent: 4,508,905

Title: Substituted 2-(-benzimidazolyl)pyridines
Abstract:The present invention relates to novel compounds of the formula ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and are each hydrogen, alkyl, halogen, carbomethoxy, carbethoxy, alkoxy, or alkanoyl, R.sup.6 is hydrogen, methyl or ethyl, R.sup.3, R.sup.4 and R.sup.5 are the same or different and are each hydrogen, methyl, methoxy, ethoxy, methoxyethoxy or ethoxyethoxy whereby R.sup.3, R.sup.4 and R.sup.5 are not all hydrogen, and whereby when two of R.sup.3, R.sup.4 and R.sup.5 are hydrogen the third of R.sup.3, R.sup.4 and R.sup.5 is not methyl. The compounds are potent gastric acid secretion inhibitors.
Inventor(s): Junggren; Ulf K. (Molnlycke, SE), Sjostrand; Sven E. (Kungsbacka, SE)
Assignee: Aktiebolaget Hassle (Molndal, SE)
Application Number:06/482,513
Patent Claim Types:
see list of patent claims

No matches for this query

Foreign Priority and PCT Information for Patent: 4,508,905

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden7804231Apr 14, 1978

International Patent Family for Patent: 4,508,905

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria374471► Subscribe
Austria374472► Subscribe
Austria374473► Subscribe
Austria375365► Subscribe
Austria389995► Subscribe
Austria406119► Subscribe
AustriaA100583► Subscribe
AustriaA100683► Subscribe
AustriaA100783► Subscribe
AustriaA141189► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Fish and Richardson
Daiichi Sankyo
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: